|
1）Boulaftali Y, Hess PR, Getz TM, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest. 2013; 123: 908-16
|
|
|
|
2）Boulaftali Y, Hess PR, Kahn ML, et al. Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res. 2014; 114: 1174-84
|
|
|
|
|
3）Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003; 102: 449-61
|
|
|
|
|
|
4）Jung SM, Moroi M. Platelet glycoprotein VI. Adv Exp Med Biol. 2008; 640: 53-63
|
|
|
|
|
|
5）Suzuki-Inoue K, Fuller GL, Garcia A, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006; 107: 542-9
|
|
|
|
|
|
6）Watson AA, Christou CM, James JR, et al. The platelet receptor CLEC-2 is active as a dimer. Biochemistry. 2009; 48: 10988-96
|
|
|
|
|
|
7）Hughes CE, Pollitt AY, Mori J, et al. CLEC-2 activates Syk through dimerization. Blood. 2010; 115: 2947-55
|
|
|
|
|
|
8）Spalton JC, Mori J, Pollitt AY, et al. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost. 2009; 7: 1192-9
|
|
|
|
|
|
9）Tsuruo T, Fujita N. Platelet aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser B Phys Biol Sci. 2008; 84: 189-98
|
|
|
|
|
10）Suzuki-Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost. 2011; 9 Suppl 1: 44-55
|
|
|
|
|
|
11）Suzuki-Inoue K, Inoue O, Ding G, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem. 2010; 285: 24494-507
|
|
|
|
|
|
12）May F, Hagedorn I, Pleines I, et al. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood. 2009; 114: 3464-72
|
|
|
|
|
|
13）Hughes CE, Navarro-Nunez L, Finney BA, et al. CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost. 2010; 8: 2328-32
|
|
|
|
|
|
14）Bender M, May F, Lorenz V, et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol. 2013; 33: 926-34
|
|
|
|
|
|
15）Davoren A, Aster RH. Heparin-induced thrombocytopenia and thrombosis. Am J Hematol. 2006; 81: 36-44
|
|
|
|
|
|
16）Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003; 121: 535-55
|
|
|
|
|
|
17）Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010; 140: 460-76
|
|
|
|
|
|
18）Bertozzi CC, Schmaier AA, Mericko P, et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood. 2010; 116: 661-70
|
|
|
|
|
|
19）Osada M, Inoue O, Ding G, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem. 2012; 287: 22241-52
|
|
|
|
|
|
20）Abtahian F, Guerriero A, Sebzda E, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science. 2003; 299: 247-51
|
|
|
|
|
|
21）Navarro-Nunez L, Langan SA, Nash GB, et al. The physiological and pathophysiological roles of platelet CLEC-2. Thromb Haemost. 2013; 109: 991-8
|
|
|
|
|
|
22）Hess PR, Rawnsley DR, Jakus Z, et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J Clin Invest. 2013;
|
|
|
|
|
|
23）Herzog BH, Fu J, Wilson SJ, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013; 502: 105-9
|
|
|
|
|
|
24）Goerge T, Ho-Tin-Noe B, Carbo C, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood. 2008; 111: 4958-64
|
|
|
|
|